S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NYSEAMERICAN:INFU

InfuSystem (INFU) Stock Forecast, Price & News

$9.80
+0.01 (+0.10%)
(As of 09/27/2023 ET)
Compare
Today's Range
$9.80
$10.07
50-Day Range
N/A
52-Week Range
$6.10
$11.44
Volume
30,581 shs
Average Volume
62,021 shs
Market Capitalization
$206.39 million
P/E Ratio
326.78
Dividend Yield
N/A
Price Target
N/A

InfuSystem MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.61% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
0.37mentions of InfuSystem in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$864,215 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars


INFU stock logo

About InfuSystem (NYSEAMERICAN:INFU) Stock

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU Price History

INFU Stock News Headlines

Lake Street Keeps Their Buy Rating on Accuray (ARAY)
Are "The Magnificent Seven" the Next Sears?
The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.
Q2 2023 Sanara Medtech Inc Earnings Call
Are "The Magnificent Seven" the Next Sears?
The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.
See More Headlines
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Company Calendar

Last Earnings
8/03/2023
Today
9/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:INFU
Employees
420
Year Founded
N/A

Profitability

Net Income
$20,000.00
Pretax Margin
0.93%

Debt

Sales & Book Value

Annual Sales
$109.91 million
Cash Flow
$0.65 per share
Book Value
$2.32 per share

Miscellaneous

Free Float
17,160,000
Market Cap
$208.49 million
Optionable
Not Optionable
Beta
1.25
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Richard A. DiIorio (Age 48)
    CEO & Director
    Comp: $806.26k
  • Ms. Carrie A. Lachance B.S.N. (Age 46)
    M.B.A., R.N., Pres, COO & Director
    Comp: $473.54k
  • Mr. Barry G. Steele (Age 52)
    Exec. VP & CFO
  • Mr. Addam Chupa (Age 44)
    Exec. VP & Chief Information Officer
  • Jeanie Latz
    Corp. Sec.













INFU Stock - Frequently Asked Questions

How have INFU shares performed in 2023?

InfuSystem's stock was trading at $9.30 on January 1st, 2023. Since then, INFU stock has increased by 6.5% and is now trading at $9.90.
View the best growth stocks for 2023 here
.

Are investors shorting InfuSystem?

InfuSystem saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 296,600 shares, a decline of 15.2% from the August 31st total of 349,600 shares. Based on an average daily volume of 50,800 shares, the short-interest ratio is currently 5.8 days. Currently, 1.6% of the shares of the stock are short sold.
View InfuSystem's Short Interest
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) released its earnings results on Thursday, August, 3rd. The medical instruments supplier reported $0.02 earnings per share for the quarter. The medical instruments supplier had revenue of $31.74 million for the quarter. InfuSystem had a trailing twelve-month return on equity of 1.36% and a net margin of 0.56%.

What guidance has InfuSystem issued on next quarter's earnings?

InfuSystem updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $120.91M-, compared to the consensus revenue estimate of $120.00 million.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS).

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.92%), Meros Investment Management LP (4.23%), Ranger Investment Management L.P. (3.31%), Wasatch Advisors LP (3.30%), Cove Street Capital LLC (2.23%) and Dimensional Fund Advisors LP (1.96%). Insiders that own company stock include Blueline Capital Partners Ii,, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Kevin Whitman, Meridian Ohc Partners, Lp, Paul Andrew Gendron, R Rimmy Malhotra, Richard Dilorio and Thomas Mark Ruiz.
View institutional ownership trends
.

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $9.90.

How much money does InfuSystem make?

InfuSystem (NYSEAMERICAN:INFU) has a market capitalization of $208.49 million and generates $109.91 million in revenue each year. The medical instruments supplier earns $20,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.

How many employees does InfuSystem have?

The company employs 420 workers across the globe.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The official website for the company is ir.infusystem.com. The medical instruments supplier can be reached via phone at (124) 291-1210 or via fax at 800-455-4338.

This page (NYSEAMERICAN:INFU) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -